$TMO $DHR or even $A are experiencing a bad sales dynamic. This is the case for almost all the medical device companies. This could create opportunities for the long-term. However, their valuation remains high (PE of 35x for $TMO for instance) which is... not such a big opportunity!
I like thermo Fischer but sold it recently since it was a small position and bought more DANAHER to make this a bigger position
$TMO $DHR or even $A are experiencing a bad sales dynamic. This is the case for almost all the medical device companies. This could create opportunities for the long-term. However, their valuation remains high (PE of 35x for $TMO for instance) which is... not such a big opportunity!